C5aR1 — Drug Target

All drugs that target C5aR1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Complement inhibitor

Phase 2 pipeline (1)

• CaCP29 · InflaRx GmbH · Complement inhibitor · Immunology
  CaCP29 is a monoclonal antibody targeting the complement system.